These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24406736)

  • 1. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.
    Al-Tawfiq JA; Momattin H; Dib J; Memish ZA
    Int J Infect Dis; 2014 Mar; 20():42-6. PubMed ID: 24406736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.
    Omrani AS; Saad MM; Baig K; Bahloul A; Abdul-Matin M; Alaidaroos AY; Almakhlafi GA; Albarrak MM; Memish ZA; Albarrak AM
    Lancet Infect Dis; 2014 Nov; 14(11):1090-1095. PubMed ID: 25278221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study.
    Arabi YM; Shalhoub S; Mandourah Y; Al-Hameed F; Al-Omari A; Al Qasim E; Jose J; Alraddadi B; Almotairi A; Al Khatib K; Abdulmomen A; Qushmaq I; Sindi AA; Mady A; Solaiman O; Al-Raddadi R; Maghrabi K; Ragab A; Al Mekhlafi GA; Balkhy HH; Al Harthy A; Kharaba A; Gramish JA; Al-Aithan AM; Al-Dawood A; Merson L; Hayden FG; Fowler R
    Clin Infect Dis; 2020 Apr; 70(9):1837-1844. PubMed ID: 31925415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia.
    Khalid M; Khan B; Al Rabiah F; Alismaili R; Saleemi S; Rehan-Khaliq AM; Weheba I; Al Abdely H; Halim M; Nadri QJ; Al Dalaan AM; Zeitouni M; Butt T; Al Mutairy E
    Ann Saudi Med; 2014; 34(5):396-400. PubMed ID: 25827696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques.
    Falzarano D; de Wit E; Rasmussen AL; Feldmann F; Okumura A; Scott DP; Brining D; Bushmaker T; Martellaro C; Baseler L; Benecke AG; Katze MG; Munster VJ; Feldmann H
    Nat Med; 2013 Oct; 19(10):1313-7. PubMed ID: 24013700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases.
    Khalid M; Al Rabiah F; Khan B; Al Mobeireek A; Butt TS; Al Mutairy E
    Antivir Ther; 2015; 20(1):87-91. PubMed ID: 24831606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future treatment strategies for novel Middle East respiratory syndrome coronavirus infection.
    Adedeji AO; Sarafianos SG
    Future Med Chem; 2013 Dec; 5(18):2119-22. PubMed ID: 24261888
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating MERS-CoV during an outbreak.
    Coleman CM; Frieman MB
    Lancet Infect Dis; 2014 Nov; 14(11):1030-1031. PubMed ID: 25278219
    [No Abstract]   [Full Text] [Related]  

  • 9. IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study.
    Shalhoub S; Farahat F; Al-Jiffri A; Simhairi R; Shamma O; Siddiqi N; Mushtaq A
    J Antimicrob Chemother; 2015 Jul; 70(7):2129-32. PubMed ID: 25900158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
    Habib AMG; Ali MAE; Zouaoui BR; Taha MAH; Mohammed BS; Saquib N
    BMC Infect Dis; 2019 Oct; 19(1):870. PubMed ID: 31640578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen.
    Spanakis N; Tsiodras S; Haagmans BL; Raj VS; Pontikis K; Koutsoukou A; Koulouris NG; Osterhaus AD; Koopmans MP; Tsakris A
    Int J Antimicrob Agents; 2014 Dec; 44(6):528-32. PubMed ID: 25288266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.
    Arabi YM; Arifi AA; Balkhy HH; Najm H; Aldawood AS; Ghabashi A; Hawa H; Alothman A; Khaldi A; Al Raiy B
    Ann Intern Med; 2014 Mar; 160(6):389-97. PubMed ID: 24474051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioinformatics analysis on molecular mechanism of ribavirin and interferon-α in treating MERS-CoV].
    Zheng Y; Wang QY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):291-3. PubMed ID: 26917533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome.
    Kim UJ; Won EJ; Kee SJ; Jung SI; Jang HC
    Antivir Ther; 2016; 21(5):455-9. PubMed ID: 26492219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
    Al-Tawfiq JA; Memish ZA
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):269-275. PubMed ID: 27937060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.
    Wright M; Grieve R; Roberts J; Main J; Thomas HC;
    Health Technol Assess; 2006 Jul; 10(21):1-113, iii. PubMed ID: 16750059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.
    Rosen I; Kori M; Eshach Adiv O; Yerushalmi B; Zion N; Shaoul R
    World J Gastroenterol; 2013 Feb; 19(7):1098-103. PubMed ID: 23467199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
    Momattin H; Al-Ali AY; Al-Tawfiq JA
    Travel Med Infect Dis; 2019; 30():9-18. PubMed ID: 31252170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
    Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y
    World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
    Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
    Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.